Carlsmed pioneers AI-enabled personalized spine surgery solutions through its aprevo platform, which creates patient-specific surgical plans and custom fusion devices matched to individual anatomy and alignment. The medical technology company integrates proprietary AI software with digital manufacturing processes to produce tailored implants for spine fusion procedures. It serves spine surgeons and patients by aiming to improve precision, outcomes, and efficiency in surgical care.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 12.1 | — | -6.8 | — |
| Q3 2025 | 13.1 | — | -8.5 | — |
| Q4 2025 | 15.2 | — | -8.6 | — |
| Q1 2026 | 16.1 | — | -8.7 | — |
| Q2 2026 | 18.9 | 56.8% | -10.5 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Fortress Value Acquisition Corp. V (FVAV), GigCapital9 Corp. (GIX), Galectin Therapeutics Inc. (GALT), OneIM Acquisition Corp. (OIM), Titan Acquisition Corp (TACH), L.B. Foster Company (FSTR)